TCL Archive In Brief: NCAB ask Force Supports Group-Led Data and Safety Monitoring Committees August 19, 1994
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO March 26, 2004
